| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/27/2004 | WO2004043336A2 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases |
| 05/27/2004 | WO2004043331A2 Dermastick thickened ointment |
| 05/27/2004 | WO2004043232A2 Methods for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004043229A2 Compounds for the treatment of tobacco dependence and withdrawal |
| 05/27/2004 | WO2004043228A2 Method of treating sepsis-induced ards |
| 05/27/2004 | WO2004037311A3 Device and methods for sequential, regional delivery of multiple cytotoxic agents |
| 05/27/2004 | WO2004032908A9 Method of inhibiting angiogenesis |
| 05/27/2004 | WO2004028521A3 Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders |
| 05/27/2004 | WO2004028443A3 Lipophilic diesters of chelating agent for inhibition of enzyme activity |
| 05/27/2004 | WO2004026816A8 Aromatic liver x-receptor modulators |
| 05/27/2004 | WO2004026233A3 Mannitol formulation for integrin receptor antagonist |
| 05/27/2004 | WO2004024187A3 Compositions to reduce congestion and methods for application thereof to the nasal membrane |
| 05/27/2004 | WO2004021968A3 Solution for ungual application |
| 05/27/2004 | WO2004018465A3 Benzonaphthyridines with pde 3/4 inhibiting activity |
| 05/27/2004 | WO2004017959A3 Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin |
| 05/27/2004 | WO2004016583A8 Substituted glycine derivatives for use as medicaments |
| 05/27/2004 | WO2004014881A3 '1,2,4'oxadiazoles as modulators of metabotropic glutamate receptor-5 |
| 05/27/2004 | WO2004010937A3 Method of treating cancer |
| 05/27/2004 | WO2004008147A3 Diagnosis and prevention of cancer cell invasion |
| 05/27/2004 | WO2004006842A3 Combinations of drugs for the treatment of neoplasms |
| 05/27/2004 | WO2004004725A3 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 05/27/2004 | WO2004004702A3 Method to inhibit ischemia and reperfusion injury |
| 05/27/2004 | WO2004000383A3 Polyacrylates coatings for implantable medical devices |
| 05/27/2004 | WO2003105611B1 Beverages containing plant sterols |
| 05/27/2004 | WO2003104197A9 Polymorphic form xvi of fexofenadine hydrochloride |
| 05/27/2004 | WO2003099992A3 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| 05/27/2004 | WO2003094931A8 Pharmaceutical compositions with anti-tumour activity, in particular for the treatment of leukaemia and glioblastomas |
| 05/27/2004 | WO2003094902A3 Surface treatment of sars-infected lungs |
| 05/27/2004 | WO2003088908A3 Heterocyclo inhibitors of potassium channel function |
| 05/27/2004 | WO2003086412B1 Polyphosphonate derivatives for toothpaste compositions |
| 05/27/2004 | WO2003081258A3 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs) |
| 05/27/2004 | WO2003073986A3 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/27/2004 | WO2003070245B1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists |
| 05/27/2004 | WO2003062388A9 Inhibition of rna function |
| 05/27/2004 | WO2003059276B1 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 05/27/2004 | WO2003047646A8 Resorbable polymer composition, implant and method of making implant |
| 05/27/2004 | WO2003039549A3 Selective antibacterial agents |
| 05/27/2004 | WO2003035050A3 Use of tyrosine kinase inhibitors for promoting hair growth |
| 05/27/2004 | WO2003031436A8 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 05/27/2004 | WO2003028659A3 Methods and compositions for modulating apoptosis |
| 05/27/2004 | WO2003016276A3 3-substituted oxindole beta-3 agonists |
| 05/27/2004 | WO2003011262A3 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of diseases associated with cgmp regulated processes |
| 05/27/2004 | WO2003006002A8 Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases |
| 05/27/2004 | WO2003002155B1 Vector encoding human globlin gene and use thereof in treatment of hemoglobinopathies |
| 05/27/2004 | WO2003002109A3 Use of tyrosine kinase inhibitors for treating autoimmune diseases |
| 05/27/2004 | WO2003000295A3 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 05/27/2004 | WO2002092063A3 Utilization of rutins and aescins in the treatment of ocular circulatory disturbances |
| 05/27/2004 | WO2002090375A8 Liver x receptor agonists |
| 05/27/2004 | WO2002085304A3 Proliposomal drug delivery system |
| 05/27/2004 | WO2002072088A3 Modulators of kcnq potassium channels and use thereof in treating migraine and mechanistically related diseases |
| 05/27/2004 | WO2002065977A8 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof |
| 05/27/2004 | WO2002058673A8 Method of preparing pharmaceutical or dietary compositions for conveying labile substances into the intestine |
| 05/27/2004 | WO1999046281A8 Novel polypeptides and nucleic acids encoding the same |
| 05/27/2004 | US20040102758 Medical devices, drug coatings and methods for maintaining the drug coatings thereon |
| 05/27/2004 | US20040102652 For treatment of cardiovascular disorders/heart failure |
| 05/27/2004 | US20040102651 Comprises reduction of 1-phenyl-3-methylamino-1-propen-1-one with sodium borohydride and acetic acid to form 3-methylamino-1-phenyl-1-propanol |
| 05/27/2004 | US20040102650 Reacting hexachloroacetone with solvent-suspended resin-bound triphenylphosphine, chlorinating retinoic acid to provide retinoyl chloride, then stirring in pyridine; chromatography; for induction of apoptosis in cancer cells |
| 05/27/2004 | US20040102638 Polymorphs of bicifadine hydrochloride |
| 05/27/2004 | US20040102636 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| 05/27/2004 | US20040102633 For therapy and prophylaxis of chronic obstructive pulmonary disease (COPD), asthma, airway hyper- reactivity, cough; inflammatory diseases such as inflammatory bowel disease, psoriasis, fibrositis, osteoarthritis |
| 05/27/2004 | US20040102630 For therapy of cancer, auto-immune diseases, cardiovascular diseases, infectious diseases, nephrological diseases, neurodegenerative diseases and viral infections |
| 05/27/2004 | US20040102626 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use cardiovascular preparations |
| 05/27/2004 | US20040102609 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 05/27/2004 | US20040102527 Use of cyclohexenone derivatives in the manufacture of a medicament for treating diabetic complications |
| 05/27/2004 | US20040102526 Use of aloe-emodin in the treatment of neuroectodermal tumors |
| 05/27/2004 | US20040102525 Compositions and methods of treating neurological disease and providing neuroprotection |
| 05/27/2004 | US20040102524 Method of treatment |
| 05/27/2004 | US20040102523 Modafinil polymorphic forms |
| 05/27/2004 | US20040102520 Use of (r) - ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs |
| 05/27/2004 | US20040102519 Use of arachidonic acid as a method of increasing skeletal muscle mass |
| 05/27/2004 | US20040102518 Antidiabetic agents |
| 05/27/2004 | US20040102517 Novel1,2-diphenylethene derivatives for treatment of immune diseases |
| 05/27/2004 | US20040102515 Deprotecting a xanthenenone compound containing O-protecting group and a oxirane ring substitued with methyl containing a leaving group in presence of palladium/barium sulfate and 1,4-dicyclohexadiene, or Raney Nickel |
| 05/27/2004 | US20040102514 Novel multi-ring organic compounds for regulating gut motility and food intake |
| 05/27/2004 | US20040102512 Statins reduce or repress T-lymphocyte activation mediated by MHC class II or CD40; new target is alternative to cytokine inhibitors |
| 05/27/2004 | US20040102510 Cancer; the compounds interact with the amino acids in the catalytic region of PKs and bind in the general space normally occupied by the adenine ring of ATP |
| 05/27/2004 | US20040102508 Naphathalene derivatives which bind to the ep4 receptor |
| 05/27/2004 | US20040102507 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 05/27/2004 | US20040102506 Pyrazole compositions useful as inhibitors of ERK |
| 05/27/2004 | US20040102504 Compositions based on aminoacids, suitable for the treatment of heart failure |
| 05/27/2004 | US20040102502 Preventing/remedies for portal hypertension |
| 05/27/2004 | US20040102501 Stable, low free formaldehyde, synergistic antimicrobial compositions of aldehyde donors and dehydroacetic acid |
| 05/27/2004 | US20040102500 Peroxisome proliferator activated receptor alpha agonists |
| 05/27/2004 | US20040102499 EP4 agonists as agents for lowering intraocular pressure |
| 05/27/2004 | US20040102498 Estrogen receptor modulators |
| 05/27/2004 | US20040102497 Novel inhibitors of IMPDH enzyme |
| 05/27/2004 | US20040102496 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 05/27/2004 | US20040102495 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 05/27/2004 | US20040102490 Antilipemic agents, antidiabetic agents and treatment of obesity |
| 05/27/2004 | US20040102486 Novel method of treatment |
| 05/27/2004 | US20040102485 Tartrate salt of thiazolidinedione derivative |
| 05/27/2004 | US20040102484 Prodrugs of proton pump inhibitors |
| 05/27/2004 | US20040102483 Chemical compounds |
| 05/27/2004 | US20040102482 Antibacterial Mutilins |
| 05/27/2004 | US20040102481 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 05/27/2004 | US20040102479 Novel benzopyran or thiobenzopyran derivatives |
| 05/27/2004 | US20040102477 Polymorphic forms of (S)-Repaglinide and the processes for preparation thereof |
| 05/27/2004 | US20040102476 High concentration formulations of opioids and opioid derivatives |
| 05/27/2004 | US20040102475 Methods for treatment of erectile dysfunction |
| 05/27/2004 | US20040102474 Dietetics; antidiabetic agents; eating disorders |